Continued Investment in AI Drug Discovery Points to Potential Future Significance of Inventorship in Biosimilar Litigation December 20, 2024
New BPCIA Case Filed: Genentech and Biogen Want to Stop Dr. Reddy’s Rituximab Biosimilar from Entering the U.S. Market December 1, 2023
